Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4% is a novel corrective eye drop indicated for the treatment of presbyopia in adults. Qlosi's formulation includes the lowest effective ...

In an order dated September 10, the Drugs Controller General of India (DCGI) noted that permission had been granted on August 20 for the manufacture and marketing of Pilocarpine Hydrochloride ...

ISOPTO CARPINE contains the active ingredient pilocarpine hydrochloride, which belongs to a family of medicines called parasympathomimetics. ISOPTO CARPINE is used, either alone or in combination ...

The drug contains pilocarpine hydrochloride — a plant-derived compound that has been used for decades to treat various eye conditions and dry mouth. The drops are intended for daily use ...

New Delhi: Taking serious note of Mumbai-based Entod Pharmaceuticals' claims that it can help reduce dependency on reading glasses for those suffering from presbyopia, the DCGI has suspended the ...

The directorate general of Health Services (DGHS), under the Central Drugs Standard Control Organisation (CDSCO), recently suspended ENTOD Pharmaceuticals’ licence to manufacture and market ...

HCL Technologies Ltd reported its fiscal second quarter earnings with profit at Rs 4,237 crore. (Image/Reuters) HCL Technologies Ltd on Monday reported its fiscal second quarter earnings with ...

This growth was well distributed across verticals, geographies, and offerings. HCL Software has delivered a stellar performance of 9.4 per cent YoY this quarter and 6.4 per cent growth in H1 FY25 ...

HCL Tech Dividend: HCL Technologies' board of directors announced the issue of an interim dividend for the financial year 2024-25, according to the company's BSE filing on Monday, October 14 ...

Pilocarpine HCl 1%, 2%, 4%; oph soln; contains benzalkonium chloride. Local irritation, ciliary spasm, conjunctival injection, headache, induced myopia; transient night blindness may occur (esp.